InnoGenerics was the largest Dutch generics manufacturer, producing three billion pills per year before going into bankruptcy. The company was subsequently acquired by Ofichem and restarted as Ofimedicine, continuing as a CMO for oral solid dosage forms (capsules and tablets). InnoGenerics received funding from Nordic governments during COVID-19 to support generic drug production.
oral solid dosage manufacturing, generic pharmaceuticals, high-volume tablet production, capsule manufacturing
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.